Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion evidence source_evidence_literature NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion SIO_000772 18079358 NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion wasDerivedFrom befree-20150227 NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_assertion wasGeneratedBy ECO_0000203 NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP408208.RA2O-w9ii4BsyUzbgnJN-EGxO5wehOG_AvMxYTw4ftm5Q130_provenance.